Biology Reference
In-Depth Information
41. Gavard J, Gutkind JS. (2008) Protein kinase C-related kinase and ROCK are required
for thrombin-induced endothelial cell permeability downstream from Galpha12/13 and
Galpha11/q. J Biol Chem 283:29888-96.
42. Germack R, Griffin M, Dickenson JM. (2004) Activation of protein kinase B by adenosine
A1 and A3 receptors in newborn rat cardiomyocytes. J Mol Cell Cardiol 37:989-99.
43. Govers R, Rabelink TJ. (2001) Cellular regulation of endothelial nitric oxide synthase. Am
J Physiol Renal Physiol 280:F193-206.
44. Hammarberg C, Fredholm BB, Schulte G. (2004) Adenosine A3 receptor-mediated regu-
lation of p38 and extracellular-regulated kinase ERK1/2 via phosphatidylinositol-3
-kinase.
Biochem Pharmacol 67:129-34.
45. Hirano S, Rees RS, Yancy SL, Welsh MJ, Remick DG, Yamada T, Hata J, Gilmont RR.
(2004) Endothelial barrier dysfunction caused by LPS correlates with phosphorylation of
HSP27 in vivo. Cell Biol Toxicol 20:1-14.
46. Hoffmann C, Ziegler N, Reiner S, Krasel C, Lohse MJ. (2008) Agonist-selective, receptor-
specific interaction of human P2Y receptors with beta-arrestin-1 and -2. J Biol Chem
283:30933-41.
47. Holinstat M, Mehta D, Kozasa T, Minshall RD, Malik AB. (2003) Protein kinase Calpha-
induced p115RhoGEF phosphorylation signals endothelial cytoskeletal rearrangement.
J Biol Chem 278:28793-8.
48. Houslay MD, Baillie GS. (2003) The role of ERK2 docking and phosphorylation of PDE4
cAMP phosphodiesterase isoforms in mediating cross-talk between the cAMP and ERK
signalling pathways. Biochem Soc Trans 31:1186-90.
49. Iwami G, Kawabe J, Ebina T, Cannon PJ, Homcy CJ, Ishikawa Y. (1995) Regulation of
adenylyl cyclase by protein kinase A. J Biol Chem 270:12481-4.
50. Iyer S, Ferreri DM, DeCocco NC, Minnear FL, Vincent PA. (2004) VE-cadherin-p120 inter-
action is required for maintenance of endothelial barrier function. Am J Physiol Lung Cell
Mol Physiol 286:L1143-53.
51. Klinger M, Freissmuth M, Nanoff C. (2002) Adenosine receptors: G protein-mediated
signalling and the role of accessory proteins. Cell Signal 14:99-108.
52. Knezevic N, Roy A, Timblin B, Konstantoulaki M, Sharma T, Malik AB, Mehta D.
(2007) GDI-1 phosphorylation switch at serine 96 induces RhoA activation and increased
endothelial permeability. Mol Cell Biol 27:6323-33.
53. Koesling D, Mullershausen F, Lange A, Friebe A, Mergia E, Wagner C, Russwurm M.
(2005) Negative feedback in NO/cGMP signalling. Biochem Soc Trans 33:1119-22.
54. Kolosova IA, Mirzapoiazova T, Adyshev D, Usatyuk P, Romer LH, Jacobson JR,
Natarajan V, Pearse DB, Garcia JG, Verin AD. (2005) Signaling pathways involved
in adenosine triphosphate-induced endothelial cell barrier enhancement. Circ Res 97:
115-24.
55. Kolosova IA, Mirzapoiazova T, Moreno-Vinasco L, Sammani S, Garcia JG, Verin AD.
(2008) Protective effect of purinergic agonist ATPgammaS against acute lung injury. Am
J Physiol Lung Cell Mol Physiol 294:L319-24.
56. Kozasa T, Jiang X, Hart MJ, Sternweis PM, Singer WD, Gilman AG, Bollag G,
Sternweis PC. (1998) p115 RhoGEF, a GTPase activating protein for Galpha12 and
Galpha13. Science 280:2109-11.
57. Krause M, Dent EW, Bear JE, Loureiro JJ, Gertler FB. (2003) Ena/VASP proteins: regulators
of the actin cytoskeleton and cell migration. Annu Rev Cell Dev Biol 19:541-64.
58. Liao Z, Seye CI, Weisman GA, Erb L. (2007) The P2Y2 nucleotide receptor requires
interaction with alpha v integrins to access and activate G12. J Cell Sci 120:1654-62.
59. Loffler M, Morote-Garcia JC, Eltzschig SA, Coe IR, Eltzschig HK. (2007) Physiological
roles of vascular nucleoside transporters. Arterioscler Thromb Vasc Biol 27:1004-13.
60. Lynge J, Schulte G, Nordsborg N, Fredholm BB, Hellsten Y. (2003) Adenosine A 2B recep-
tors modulate cAMP levels and induce CREB but not ERK1/2 and p38 phosphorylation in
rat skeletal muscle cells. Biochem Biophys Res Commun 307:180-7.
Search WWH ::
Custom Search